Literature DB >> 35668288

Insomnia and Upper Airway Stimulation Therapy Benefit and Adherence: A Case Series.

Stephanie M Stahl1,2, Shalini Manchanda3,4, Noah Parker3,4, Yelena Chernyak5.   

Abstract

Obstructive sleep apnea (OSA) and insomnia are common sleep disorders that often occur concurrently. The presence of one of these disorders often negatively impacts the other, including affecting treatment benefit and adherence. While insomnia has been shown to adversely affect positive airway pressure therapy adherence, minimal data are currently available on the effects of insomnia on upper airway stimulation (UAS) therapy for the treatment of OSA. We present two cases that highlight the negative impact of insomnia on UAS therapy usage and OSA management as well as the benefits of insomnia treatment on overall outcomes. Screening for and treatment of insomnia prior to UAS implantation are recommended.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Co-morbid insomnia and sleep apnea (COMISA); Cognitive behavioral therapy for insomnia (CBT-I); Insomnia; Obstructive sleep apnea (OSA); Upper airway stimulation (UAS)

Year:  2022        PMID： 35668288     DOI： 10.1007/s10880-022-09885-6

Source DB:  PubMed          Journal:  J Clin Psychol Med Settings        ISSN： 1068-9583


  13 in total

Review 1.  Developing a successful treatment for co-morbid insomnia and sleep apnoea.

Authors:  Alexander M Sweetman; Leon C Lack; Peter G Catcheside; Nick A Antic; Ching Li Chai-Coetzer; Simon S Smith; James A Douglas; R Doug McEvoy
Journal:  Sleep Med Rev       Date:  2016-05-06       Impact factor: 11.609

2.  Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.

Authors:  Børge Sivertsen; Siri Omvik; Ståle Pallesen; Bjørn Bjorvatn; Odd E Havik; Gerd Kvale; Geir Høstmark Nielsen; Inger Hilde Nordhus
Journal:  JAMA       Date:  2006-06-28       Impact factor: 56.272

3.  Insomnia in untreated sleep apnea patients compared to controls.

Authors:  Erla Björnsdóttir; Christer Janson; Thorarinn Gíslason; Jón F Sigurdsson; Allan I Pack; Philip Gehrman; Bryndís Benediktsdóttir
Journal:  J Sleep Res       Date:  2011-10-12       Impact factor: 3.981

4.  Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: a randomized clinical trial.

Authors:  Alexander Sweetman; Leon Lack; Peter G Catcheside; Nick A Antic; Simon Smith; Ching Li Chai-Coetzer; James Douglas; Amanda O'grady; Nicola Dunn; Jan Robinson; Denzil Paul; Paul Williamson; R Doug McEvoy
Journal:  Sleep       Date:  2019-12-24       Impact factor: 5.849

5.  Comorbid insomnia and sleep apnoea is associated with all-cause mortality.

Authors:  Bastien Lechat; Sarah Appleton; Yohannes Adama Melaku; Kristy Hansen; R Doug McEvoy; Robert Adams; Peter Catcheside; Leon Lack; Danny J Eckert; Alexander Sweetman
Journal:  Eur Respir J       Date:  2022-07-13       Impact factor: 33.795

6.  Symptoms of insomnia among patients with obstructive sleep apnea before and after two years of positive airway pressure treatment.

Authors:  Erla Björnsdóttir; Christer Janson; Jón F Sigurdsson; Philip Gehrman; Michael Perlis; Sigurdur Juliusson; Erna S Arnardottir; Samuel T Kuna; Allan I Pack; Thorarinn Gislason; Bryndis Benediktsdóttir
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

7.  Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial.

Authors:  Christopher J Lettieri; Anita A Shah; Aaron B Holley; William F Kelly; Audrey S Chang; Stuart A Roop
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

8.  Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS).

Authors:  Simon Smith; Karen Sullivan; Wendy Hopkins; James Douglas
Journal:  Sleep Med       Date:  2004-09       Impact factor: 3.492

9.  Prospective randomized study of patients with insomnia and mild sleep disordered breathing.

Authors:  Christian Guilleminault; Kala Davis; Nelly T Huynh
Journal:  Sleep       Date:  2008-11       Impact factor: 5.849

10.  A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome.

Authors:  Russell Rosenberg; James M Roach; Martin Scharf; David A Amato
Journal:  Sleep Med       Date:  2007-05-18       Impact factor: 3.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.